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Commercial fluorometholone, CAS #426-13-1, crystallizes in the monoclinic space group P21 (#4)
with a = 6.40648(2), b = 13.43260(5), c = 11.00060(8) Å, β = 92.8203(5)°, V = 945.517(5) Å3, and
Z = 2. A reduced cell search in the Cambridge Structural Database yielded one previous structure
determination, using single-crystal data at 292 K. In this work, the sample was ordered from the
United States Pharmacopeial Convention (Lot # R032K0) and analyzed as-received. The room tem-
perature (295 K) crystal structure was refined using synchrotron (λ = 0.412826 Å) powder diffraction
data and optimized using density functional theory (DFT) techniques. Hydrogen positions were
included as a part of the structure and were re-calculated during the refinement. The diffraction
data were collected on beamline 11-BM at the Advanced Photon Source, Argonne National
Laboratory, and the powder X-ray diffraction pattern of the compound has been submitted to
ICDD® for inclusion in the Powder Diffraction File™. The agreement of the Rietveld-refined and
DFT-optimized structures is excellent; the root-mean-square Cartesian displacement is 0.060 Å. In
addition to the O–H⋯O hydrogen bonds observed by Park et al. (Park, Y. J., Lee, M. Y., and
Cho, S. I. (1992). “Fluorometholone,” J. Korean Chem. Soc. 36, 812–817), C–H⋯O hydrogen
bonds contribute to the crystal energy. © 2020 International Centre for Diffraction Data.
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Fluorometholone (brand names: Efflumidex, Flucon,
FML Forte, and FML) is a prescription drug classified as a
synthetic glucocorticoid used to treat optical inflammation or
diseases. Commercial fluorometholone, CAS #426-13-1, crys-
tallizes in the monoclinic space group P21 (#4) with a =
6.40648(2), b = 13.43260(5), c = 11.00060(8) Å, β = 92.8203
(5)°, V = 945.517(5) Å3, and Z = 2. A reduced cell search in
the Cambridge Structural Database (Groom et al., 2016)
yielded one previous structure determination (Park et al.,
1992), using single-crystal data at 292 K.
In this work, the sample was ordered from the United
States Pharmacopeial Convention (Lot # R032K0) and ana-
lyzed as-received. The diffraction data were collected on
beamline 11-BM at the Advanced Photon Source, Argonne
National Laboratory. The room temperature (295 K) crystal
structure was refined using synchrotron (λ = 0.412826 Å)
powder diffraction data and optimized using density func-
tional theory (DFT) techniques. Hydrogen positions were
included as a part of the structure and were re-calculated dur-
ing the refinement (Figure 1).
The agreement of the Rietveld-refined and DFT-opti-
mized structures is excellent; the root-mean-square Cartesian
displacement is 0.060 Å. In addition to the O–H⋯O hydrogen
bonds observed by Park et al. (1992), C–H⋯O hydrogen
bonds contribute to the crystal energy (Table I). The powder
X-ray diffraction pattern of the compound has been submitted
to ICDD® for inclusion in the Powder Diffraction File™.
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CIF and/or RAW data files were deposited with ICDD.
You may request this data from ICDD at info@icdd.com.
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TABLE I. Hydrogen bonds (CRYSTAL14) in fluorometholone.
H-bond D–H (Å) H⋯A (Å) D⋯A (Å) D–H⋯A (°) Overlap (e) E (kcal mol−1)
O3–H29⋯O1 0.980 1.784 2.753 169.1 0.050 12.2
O2–H28⋯O3 0.979 1.892 2.835 160.7 0.059 13.3
C22–H27⋯O4 1.094 2.599 3.686 172.5 0.012 a
C21–H23⋯O1 1.096 2.525 3.567 158.5 0.017 a
C16–H14⋯O4 1.091 2.387b 2.840 103.1 0.014 a
C1–H1⋯O4 1.087 2.515 3.598 173.4 0.020 a
aCorrelation between overlap population and hydrogen bond energy not yet available for C–H⋯O hydrogen bonds.
bIntramolecular.
Figure 1. Powder X-ray diffraction pattern of fluorometholone. The Rietveld-refined structure is indicated in red, and the DFT-optimized structure is indicated in
blue.
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